Alto Neuroscience, Inc. (ANRO) Tops Q3 EPS by 12c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.52), $0.12 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• SK Hynix vs. Micron deep dive: who wins the AI memory supercycle?
• Goldman Sachs (GS) PT Raised to $1,190 at BMO Capital
• Guardant Health (GH) PT Raised to $200 at TD Cowen on 'Meaningfully Higher' Forecasts